153 related articles for article (PubMed ID: 10684728)
1. Generational analysis reveals that TGF-beta1 inhibits the rate of angiogenesis in vivo by selective decrease in the number of new vessels.
Parsons-Wingerter P; Elliott KE; Farr AG; Radhakrishnan K; Clark JI; Sage EH
Microvasc Res; 2000 Mar; 59(2):221-32. PubMed ID: 10684728
[TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of angiogenesis in small blood vessels and decrease in vessel diameter throughout the vascular tree by triamcinolone acetonide.
McKay TL; Gedeon DJ; Vickerman MB; Hylton AG; Ribita D; Olar HH; Kaiser PK; Parsons-Wingerter P
Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1184-90. PubMed ID: 18326748
[TBL] [Abstract][Full Text] [Related]
3. A novel assay of angiogenesis in the quail chorioallantoic membrane: stimulation by bFGF and inhibition by angiostatin according to fractal dimension and grid intersection.
Parsons-Wingerter P; Lwai B; Yang MC; Elliott KE; Milaninia A; Redlitz A; Clark JI; Sage EH
Microvasc Res; 1998 May; 55(3):201-14. PubMed ID: 9657920
[TBL] [Abstract][Full Text] [Related]
4. A VEGF165-induced phenotypic switch from increased vessel density to increased vessel diameter and increased endothelial NOS activity.
Parsons-Wingerter P; Chandrasekharan UM; McKay TL; Radhakrishnan K; DiCorleto PE; Albarran B; Farr AG
Microvasc Res; 2006 Nov; 72(3):91-100. PubMed ID: 16872639
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor-2 selectively stimulates angiogenesis of small vessels in arterial tree.
Parsons-Wingerter P; Elliott KE; Clark JI; Farr AG
Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1250-6. PubMed ID: 10807740
[TBL] [Abstract][Full Text] [Related]
6. Nerve growth factor (NGF) promotes angiogenesis in the quail chorioallantoic membrane.
Lazarovici P; Gazit A; Staniszewska I; Marcinkiewicz C; Lelkes PI
Endothelium; 2006; 13(1):51-9. PubMed ID: 16885067
[TBL] [Abstract][Full Text] [Related]
7. Launch conditions might affect the formation of blood vessels in the quail chorioallantoic membrane.
Henry MK; Unsworth BR; Sychev V; Guryeva TS; Dadasheva OA; Piert SJ; Lagel KE; Dubrovin LC; Jahns GC; Boda K; Sabo V; Samet MM; Lelkes PI
Folia Vet; 1998; 42 Suppl():S25-31. PubMed ID: 11543304
[TBL] [Abstract][Full Text] [Related]
8. Quantitation of angiogenesis in the chick chorioallantoic membrane model using fractal analysis.
Kirchner LM; Schmidt SP; Gruber BS
Microvasc Res; 1996 Jan; 51(1):2-14. PubMed ID: 8812748
[TBL] [Abstract][Full Text] [Related]
9. Normal patterns of angiogenesis and extracellular matrix deposition in chick chorioallantoic membranes are disrupted by mainstream and sidestream cigarette smoke.
Melkonian G; Le C; Zheng W; Talbot P; Martins-Green M
Toxicol Appl Pharmacol; 2000 Feb; 163(1):26-37. PubMed ID: 10662602
[TBL] [Abstract][Full Text] [Related]
10. Opioid growth factor modulates angiogenesis.
Blebea J; Mazo JE; Kihara TK; Vu JH; McLaughlin PJ; Atnip RG; Zagon IS
J Vasc Surg; 2000 Aug; 32(2):364-73. PubMed ID: 10917997
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity.
Fujiwara M; Muragaki Y; Ooshima A
Arch Dermatol Res; 2005 Oct; 297(4):161-9. PubMed ID: 16184401
[TBL] [Abstract][Full Text] [Related]
12. A new intra-arterial delivery platform for pro-arteriogenic compounds to stimulate collateral artery growth via transforming growth factor-beta1 release.
Grundmann S; van Royen N; Pasterkamp G; Gonzalez N; Tijsma EJ; Piek JJ; Hoefer IE
J Am Coll Cardiol; 2007 Jul; 50(4):351-8. PubMed ID: 17659203
[TBL] [Abstract][Full Text] [Related]
13. Osteocalcin is angiogenic in vivo.
Cantatore FP; Crivellato E; Nico B; Ribatti D
Cell Biol Int; 2005 Jul; 29(7):583-5. PubMed ID: 15979904
[TBL] [Abstract][Full Text] [Related]
14. A novel early chorioallantoic membrane assay demonstrates quantitative and qualitative changes caused by antiangiogenic substances.
Hazel SJ
J Lab Clin Med; 2003 Mar; 141(3):217-28. PubMed ID: 12624603
[TBL] [Abstract][Full Text] [Related]
15. Novel function of ascorbic acid as an angiostatic factor.
Ashino H; Shimamura M; Nakajima H; Dombou M; Kawanaka S; Oikawa T; Iwaguchi T; Kawashima S
Angiogenesis; 2003; 6(4):259-69. PubMed ID: 15166494
[TBL] [Abstract][Full Text] [Related]
16. Anti-angiogenic properties of myo-inositol trispyrophosphate in ovo and growth reduction of implanted glioma.
Sihn G; Walter T; Klein JC; Queguiner I; Iwao H; Nicolau C; Lehn JM; Corvol P; Gasc JM
FEBS Lett; 2007 Mar; 581(5):962-6. PubMed ID: 17316624
[TBL] [Abstract][Full Text] [Related]
17. A novel quantitative chick embryo assay as an angiogenesis model using digital image analysis.
Peifer C; Dannhardt G
Anticancer Res; 2004; 24(3a):1545-51. PubMed ID: 15274321
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor fails to acutely modulate endothelial permeability during early angiogenesis in the chick chorioallantoic membrane.
DeFouw LM; DeFouw DO
Microvasc Res; 2000 Nov; 60(3):212-21. PubMed ID: 11078637
[TBL] [Abstract][Full Text] [Related]
19. Growth and angiogenesis are inhibited in vivo in developing tissues by pyrazine and its derivatives.
Melkonian G; Eckelhoefer H; Wu M; Wang Y; Tong C; Riveles K; Talbot P
Toxicol Sci; 2003 Oct; 75(2):393-401. PubMed ID: 12773771
[TBL] [Abstract][Full Text] [Related]
20. The neurotrophic pyrimidine heterocyclic compound MS-818 promotes the angiogenesis induced by basic FGF.
Yasuhara S; Kashiwagi S; Ito H; Awaya A
Int J Clin Pharmacol Res; 1995; 15(5-6):167-74. PubMed ID: 8835614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
